Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Controls
Imatinib/Norimatinib/Dasatinib/Nilotinib - HPLC
Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Controls, lyophilised
0224 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 2 ml
0225 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Level I (lyoph.), 5 x 2 ml
0226 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Level II (lyoph.), 5 x 2 ml
These lyophilised quality controls from Chromsystems are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of imatinib, norimatinib, dasatinib and nilotinib in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.
| Concentrations | Please note: All concentrations shown here are exemplatory. They do not reflect real data for the described products. Actual concentrations depend on the production lot of each product and can exclusively be found in the product information leaflet. Please ask for these product information leaflets or download them from the service site of the Chromsystems website.
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Storage conditions | Stored below -18 °C and unopened, the lyophilised controls are stable until the expiry date specified on the vial labels. The reconstituted controls can be stored up to 3 weeks tightly capped at +2 to +8 C. If the controls cannot be used within this period, they should be aliquoted and stored frozen below -18 °C (up to 3 months). For more details about storage conditions please check your product information leaflet. |
||||||||||||||||||||||||||||||
| Method of Analysis | HPLC | ||||||||||||||||||||||||||||||
| Parameters | Dasatinib, Imatinib, Nilotinib, Norimatinib |
Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Controls, lyophilised
0224 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 2 ml
0225 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Level I (lyoph.), 5 x 2 ml
0226 Imatinib/Norimatinib/Dasatinib/Nilotinib Plasma Control, Level II (lyoph.), 5 x 2 ml
These lyophilised quality controls from Chromsystems are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of imatinib, norimatinib, dasatinib and nilotinib in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.
| Concentrations | Please note: All concentrations shown here are exemplatory. They do not reflect real data for the described products. Actual concentrations depend on the production lot of each product and can exclusively be found in the product information leaflet. Please ask for these product information leaflets or download them from the service site of the Chromsystems website.
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Storage conditions | Stored below -18 °C and unopened, the lyophilised controls are stable until the expiry date specified on the vial labels. The reconstituted controls can be stored up to 3 weeks tightly capped at +2 to +8 C. If the controls cannot be used within this period, they should be aliquoted and stored frozen below -18 °C (up to 3 months). For more details about storage conditions please check your product information leaflet. |
||||||||||||||||||||||||||||||
| Method of Analysis | HPLC | ||||||||||||||||||||||||||||||
| Parameters | Dasatinib, Imatinib, Nilotinib, Norimatinib |